Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product

American Journal of Pathology

Volumn 152, Issue 4, 1998, Pages 865-869

  Gulley, Margaret L ^a   Nicholls, John M ^b   Schneider, Barbara G ^c   Amin, Mahul B ^d   Ro, Jae Y ^e   Geradts, Joseph ^f  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NASOPHARYNGEAL NEOPLASMS; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES; RNA, VIRAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031919421     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Choi PH, Suen MW, Huang DP, Lo KW, Lee JC: Nasopharyngeal carcinoma: genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients. Cancer 1993, 72:2873-2878
2. Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, Yarbrough WG: Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 1997, 14:811-818
3. Papadimitrakopoulou V, Izzo J, Lippman SM, Lee JS, Fan YH, Clayman G, Ro JY, Hittelman WN, Lotan R, Hong WK, Mao L: Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 1997, 14:1799-1803
4. Liggett W Jr, Sewell DA, Rocco J, Ahrendt SA, Koch W, Sidransky D: p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res 1996, 56:4119-4123
5. Kiaris H, Spanakis N, Ergazaki M, Sourvinos G, Spandidos DA: Loss of heterozygosity at 9p and 17q in human laryngeal tumors. Cancer Lett 1995, 97:129-134
6. Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, Ewen ME, Rollins BJ: Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 1995, 55:6200-6209
7. Huang DP, Lo KW, van Hasselt CA, Woo JK, Choi PH, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JC: A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 1994, 54:4003-4006
8. Lo KW, Huang DP, Lau KM: p16 gene alterations in nasopharyngeal carcinoma. Cancer Res 1995, 55:2039-2043
9. Lo KW, Cheung ST, Leung SF, van Hasselt A, Tsang YS, Mak KF, Chung YF, Woo JK, Lee JC, Huang DP: Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 1996, 56:2721-2725
10. Sun Y, Hildesheim A, Lanier AE, Cao Y, Yao KT, Raab-Traub N, Yang CS: No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas. Oncogene 1995, 10:785-788
11. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996, 56:3630-3633
12. Geradts J, Kratzke RA, Niehans GA, Lincoln CE: Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995, 55:6006-6011
13. Gleich LL, Li YQ, Biddinger PW, Gartside PS, Stambrook PJ, Pavelic ZP, Gluckman JL: The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer. Laryngoscope 1996, 106:1378-1381
14. Yokoyama J, Shiga K, Sasano H, Suzuki M, Takasaka T: Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers. Anticancer Res 1996, 16:641-644
15. Yoo GH, Xu HJ, Brennan JA, Westra W, Hruban RH, Koch W, Benedict WF, Sidransky D: Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994, 54:4603-4606
16. Sun Y, Hegamyer G, Colburn NH: Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations. Oncogene 1993, 8:791-795
17. Gulley ML, Burton MP, Allred CA, Nicholls JM, Amin MB, Ro JY, Schneider BG: Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. Hum Pathol 1998, 29: 252-259
18. Geradts J, Kratzke RA, Crush-Stanton S, Wen SF, Lincoln CE: Wild- type and mutant retinoblastoma protein in paraffin sections. Mod Pathol 1996, 9:339-347
19. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995, 55:4525-4530
20. Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW, Anderson MW: Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res 1997, 57:1-6
21. Geradts J, Wilson PA: High frequency of aberrant p16(INK4A) expression in human breast cancer. Am J Pathol 1996, 149:15-20
22. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995, 1:686-692
23. Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA, Geradts J: Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res 1996, 56:3415-3420
24. Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Minna JD, Hong WK, Mao L: Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res 1997, 57:400-403
25. Kratzke RA, Otterson GA, Lincoln CE, Ewing S, Oie H, Geradts J, Kaye FJ: Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma. J Natl Cancer Inst 1995, 87:1870-1875
26. Schutte M HR, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskalukl CA, Hahn SA, Scwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG: Abrogation of the RB/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997, 57:3126-3130